Business Description

Description
BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.
Name Current Vs Industry Vs History
Cash-To-Debt 97.63
Equity-to-Asset 0.66
Debt-to-Equity 0.01
Debt-to-EBITDA -0.18
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.26
Distress
Grey
Safe
Beneish M-Score -2.77
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 99.56
9-Day RSI 98.29
14-Day RSI 97
6-1 Month Momentum % -2.63
12-1 Month Momentum % 98.92

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.68
Quick Ratio 5.3
Cash Ratio 4.71
Days Inventory 167.78
Days Sales Outstanding 47.79
Days Payable 30.66

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -14.3
Shareholder Yield % 0.02

Financials (Next Earnings Date:2024-05-08)

BRSYF's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:BRSYF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

BrainsWay Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 31.785
EPS (TTM) ($) -0.13
Beta 27.31
Volatility % 63.25
14-Day RSI 97
14-Day ATR ($) 0.020214
20-Day SMA ($) 2.222
12-1 Month Momentum % 98.92
52-Week Range ($) 0.897 - 2.5
Shares Outstanding (Mil) 33.27

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

BrainsWay Ltd Filings

Filing Date Document Date Form
No Filing Data

BrainsWay Ltd Stock Events

Financials Calendars
Event Date Price($)
No Event Data

BrainsWay Ltd Frequently Asked Questions

What is BrainsWay Ltd(BRSYF)'s stock price today?
The current price of BRSYF is $2.47. The 52 week high of BRSYF is $2.50 and 52 week low is $0.90.
When is next earnings date of BrainsWay Ltd(BRSYF)?
The next earnings date of BrainsWay Ltd(BRSYF) is 2024-05-08.
Does BrainsWay Ltd(BRSYF) pay dividends? If so, how much?
BrainsWay Ltd(BRSYF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1